Bibliografia

1. Pontieri G, Russo M, Frati L. Patologia generale, IV edizione. Padova: Piccin, 2010; 399-401.
2. Selye H. The stress of life. New York: Mc Graw Hill, 1976.
3. Di Pierro F. Roles of chemical complexity and evolutionary theory in some hepatic and intestinal enzymatic systems in chemical reproducibility and clinical efficiency of herbal derivatives. The Scientific World Journal, Volume 2014, Article ID 732045, 12 pages.
4. Jurenka JS. Anti-inflammatory properties of curcumin, a major constituent of curcuma longa: a review of preclinical and clinical research. Altern Med Rev 2009; 14(2): 141-53.
5. Aggarwal BB, Sung B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci 2009; 30(2): 85-94.
6. Jain SK, Rains J, Croad J, Larson B, Jones K. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal 2009; 11(2): 241-9.
7. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 2001; 21: 2895-900.
8. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm 2007; 4(6): 807-18.
9. Kidd PM. Bioavailability and activity of phytosome complexes from botanical polyphenols: the silymarin, curcumin, green tea, and grape seed extracts. Altern Med Rev 2009; 14(3): 226-46.
10. Bhardwaj RK, Glaeser H, Becquemont L, et al. Piperi­ne, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002; 302(2): 645-50.
11. Shoba G, Joy D, Joseph T, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med 1998; 64(4): 353-6.
12. Di Pierro F, Rapacioli G, Di Maio EA, et al. Comparative evaluation of the pain-relieving properties of a lecithinized formulation of curcumin (Meriva®), nimesulide, and acetaminophen. J Pain Res 2013; 6: 201-5.
13. Di Pierro F, Settembre R. Safety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofen. J Pain Res 2013; 6: 497-503.
14. Siddiqui MZ. Boswellia serrata, a potential anti-inflammatory agent: an overview. Indian J Pharm Sci 2011; 73(3): 255-61.
15. Krüger P, Daneshfar R, Eckert GP, et al. Metabolism of boswellic acids in vitro and in vivo. Drug Metab Dispos 2008; 36(6): 1135-42.
16. Sharma S, Thawani V, Hingorani L, et al. Pharmacokinetic study of 11-Keto beta-Boswellic acid. Phytomedicine 2004; 11(2-3): 255-60.
17. Gupta I, Gupta V, Parihar A, et al. Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study. Eur J Med Res 1998 Nov 17; 3(11): 511-4.
18. Harpagophytum procumbens (Devil’s claw) AMR 2008; 13(3): 248-52.
19. Fiebich BL, Muñoz E, Rose T, Weiss G, McGregor GP. Molecular targets of the anti-inflammatory Harpa­gophytum procumbens (devil’s claw): in­hi­bi­tion of TNFα and COX-2 gene expression by preventing activation of AP-1. Phytother Res 2012; 26(6): 806-11.
20. Lanhers MC, Fleurentin J, Mortier F. Antinflammatory and analgesic effects of an extract of H. procumbens. Planta Med 1992; 58: 117-23.
21. Di Pierro F, Rapacioli G. Estratto standardizzato di arpagofito. Formulazione a rilascio programmato per il trattamento dell’artrosi (anca, rachide e ginocchio). L’integratore nutrizionale 2010; 13(2): 1-5.

Testi di consultazione

1. Bertuccioli A, Neri M. Integrazione naturale e fitoterapia. Cesena: Edizioni Elika, 2013.
2. Tognolini M, Chiavarini M. Principi di farmacognosia e fitoterapia. Parma: Uni.Nova, 2007.